Skip to main content
. 2015 Jun 29;10(6):e0131748. doi: 10.1371/journal.pone.0131748

Fig 2. HIV-specific IFN-γ ELISpot responses.

Fig 2

HIV-specific IFN-γ ELISpot responses two weeks after the first (upper panels) and second (lower panels) HIV-MVA/gp140/placebo vaccination to A) and C) Gag CMDR peptide pool stimulation and B) and D) Env CMDR peptide pool stimulation by HIV-DNA immunization groups. Cut-off was defined as >55 SFC/106PBMCs and 4 times the background. The dashed line is set at 55. Placebo recipients are given as open circles. No statistically significant differences were found between groups.